In this issue:
BSH guideline: Fetomaternal haemorrhage estimation, 12 June 2026
BSH red cell antibodies in pregnancy recommendations
ASH guidance for severe acquired aplastic anaemia and AL amyloidosis
Australian idiopathic multicentric Castleman disease guideline
ANZSBT transfusion-transmitted CMV position statement
ICSH: laboratory-developed haemostasis test validation and monocyte lineage morphology and nomenclature
CLL/SLL and ALL access expanded by PBS from 1 June 2026
Immunoglobulin adjusted body-weight dosing from 1 July 2026
TGA provisional approval for orelabrutinib for R/R MCL
Pivekimab sunirine approved by FDA for BPDCN
FDA: Sonrotoclax approved for R/R MCL
ASH 2026: Abstract submissions opened 2 June
ANZCHOG paediatric haematology trials remain active/open in repository
PBAC July 2026 consultation closed 20 May
TGA haematology IVD listing
Conferences, Workshops, CPD
Research Review Publications
Please login below to download this issue (PDF)